Search Results
Jun 15, 2026, 08:10 ET Harbour BioMed and BioMap Jointly Initiate MegaStream TechBio: A Leading Global Drug Development Platform Joins Forces with Premier Life Science Foundation Models to Set New Benchmarks for AI-Driven Complex Biologics R&D
joining hands with long-term global partners and top-tier investors to unlock new opportunities across the industry."Mr. Wei Liu, Co-Founder and Chief Executive Officer of BioMap, said: "BioMap was built to push AI to the frontier of biology—to give drug developers a
More news about: Harbour BioMed
Jun 11, 2026, 12:30 ET CVPR 2026 Honors the Year's Most Innovative Computer Vision and AI Research
Xingyu Chen, FU-JEN CHU, Pierre Gleize, Kevin J Liang, Alexander Sax, Hao Tang, Weiyao Wang, Michelle Guo, Thibaut Hardin, Xiang Li, Aohan Lin, Jia-Wei Liu, Ziqi Ma, Anushka Sagar, Bowen Song, Xiaodong Wang, Jianing Yang, Bowen Zhang, Piotr Dollár, Georgia Gkioxari, Matt Feiszli, Jitendra Malik - A
More news about: Computer Vision Foundation (CVF)
Jun 11, 2026, 08:43 ET PhoenixAI Raises $80M Series B Led by Sky9 Capital to Power the Agentic AI Database
hundreds of millions of rows return in under a second, and this is the architecture we need for the next generation of agentic workloads."— Wei Zheng, Chief Product Officer, Conductor"PhoenixAI gives us a fast, isolated warehouse for agent workloads directly on our Apache Iceberg tables,
More news about: PhoenixAI
Jun 11, 2026, 08:00 ET WyreStorm to Release Synergy Control Flow at InfoComm 2026
and third-party control environments."Control programming has traditionally been one of the more time-consuming parts of an AV project," said Wei Jun, Vice President of Strategic Marketing. "With Synergy Control Flow, we are giving integrators an open, visual, and scalable way to deliver professional
More news about: WYRESTORM TECHNOLOGIES PROAV CORPORATION
Jun 11, 2026, 08:00 ET WyreStorm presentará Synergy Control Flow en InfoComm 2026
control de terceros."La programación de control ha sido desde siempre una de las partes que más tiempo consume en un proyecto audiovisual", afirmó Wei Jun, vicepresidente de Marketing Estratégico. "Con Synergy Control Flow, brindamos a los integradores una forma abierta, visual y escalable de proporcionar
More news about: WYRESTORM TECHNOLOGIES PROAV CORPORATION
Jun 10, 2026, 09:01 ET X-Therma Launches XT-NoVo® & TimeSeal® Platform: Shattering Cold Chain Barriers for On-Demand Regenerative Medicine
of XT-NoVo® and TimeSeal® represents a milestone in making fresh, off-the-shelf therapies a global reality," said Dr. Xiaoxi Wei, Co-founder and Chief Executive Officer of X-Therma. "By safely extending the shelf life of highly sensitive cell-based biologics from hours to days,
More news about: X-Therma Inc.
Jun 09, 2026, 08:00 ET DiMe convenes payers and virtual-first care providers to close the operational gap that leaves contracted virtual care providers invisible to patients
care can help bend the curve of chronic disease, but it only delivers at scale when the operations behind it are as strong as the clinical model," said Wei-Li Shao, President at Omada Health. "Payers need evidence, not hype, and Omada is partnering with DiMe to share insights from the playbook we have built
More news about: Digital Medicine Society (DiMe)
Jun 08, 2026, 12:23 ET NYU Langone Urologists Mark 1,000 Cryotherapy Procedures for Minimally Invasive Prostate Cancer Treatment
Perlmutter Cancer Center, has grown steadily since its first procedure in 2017. Today, NYU Langone urologic oncologists, including James S. Wysock, MD, and Wei Phin Tan, MD, have performed more than 1,000 focal cryotherapy procedures, among the highest volumes in the country.Beyond helping patients recover
More news about: NYU Langone Health
Jun 08, 2026, 08:30 ET Eco Wave Power Explores AI-Powered Wave Energy Infrastructure and WaveGPT Development with Florida Atlantic University and University of Michigan
Associate Director of SNMREC and InETech; Dr. Sasha Fung, Postdoctoral Researcher at FAU; Professor Lei Zuo of the University of Michigan; Louis King; and Wei-Ying Wong."Artificial intelligence is transforming how energy systems are designed, monitored, and optimized," said Dr. Yufei Tang, Director of
More news about: Eco Wave Power Global AB (publ)
Jun 08, 2026, 03:04 ET DL Holdings' Fourth "Victoria Harbour Night Talk": The AI Wave: Global Investment & Hong Kong Opportunities
Rice vault, and ARTiFollowing the forum panels, NeuralFin, a subsidiary of DL Holdings, held a dedicated product showcase. NeuralFin CEO Wei Hao Kiow presented the platform's upgraded brand vision and real-world applications to attendees on-site — including the ability to rapidly transform
More news about: DL Holdings
Jun 07, 2026, 23:04 ET Cumbre AGP & DTx: reducción del 0,54% de HbA1c: el cambio en el cuidado de la diabetes en terapias digitales
HbA1c, lo que confirma su eficacia en el control estructurado de la diabetes.Desde la perspectiva de los fenotipos clínicos, el Prof. Wei Qiang demostró que combinar los parámetros de rutina al ingreso con los datos del CGM y el Perfil Ambulatorio de Glucosa (AGP) puede ayudar a identificar
More news about: AGP & DTx Summit
Jun 05, 2026, 10:32 ET Konferencja AGP & DTx Summit: stosowanie terapii cyfrowych wykazuje redukcję HbA1c o 0,54%, podczas gdy metody leczenia cukrzycy przechodzą od monitorowania do zmiany
punktów procentowych, co umacnia rolę tych terapii w usystematyzowanym leczeniu cukrzycy.Z punktu widzenia fenotypów klinicznych, prof. Wei Qiang wykazał, że połączenie rutynowych pomiarów w ramach przyjęcia do szpitala z danymi CGM i AGP może pomóc w identyfikacji fenotypów metabolicznych
More news about: AGP & DTx Summit
Jun 05, 2026, 05:49 ET AGP & DTx Summit: Digitale Therapeutika senken den HbA1c-Wert um 0,54 %, während die Diabetesversorgung einen Wandel von der Überwachung hin zur Verhaltensänderung vollzieht
HbA1c-Werts um 0,54 Prozentpunkte einherging, was den Wert dieser Methode im Rahmen strukturierter Diabetesinterventionen unterstreicht.Prof. Wei Qiang zeigte aus Sicht der klinischen Phänotypisierung, dass die Kombination von routinemäßigen Aufnahmedaten mit CGM- und AGP-Daten dazu beitragen
More news about: AGP & DTx Summit
Jun 05, 2026, 05:48 ET Sommet AGP & DTx : les thérapies numériques permettent une réduction de 0,54 % de l'HbA1c alors que la prise en charge du diabète passe de la surveillance au changement
réaffirmant leur valeur dans le cadre d'une intervention structurée contre le diabète.Du point de vue du phénotypage clinique, le professeur Wei Qiang a montré que la combinaison des paramètres d'admission de routine avec les données CGM et AGP pouvait aider à identifier les phénotypes métaboliques
More news about: AGP & DTx Summit
Jun 05, 2026, 04:45 ET Summit AGP & DTx: digitální terapeutika prokazuje snížení HbA1c o 0,54 % v době, kdy se péče o diabetiky posouvá od monitorování k aktivní změně
snížením HbA1c o 0,54 procentního bodu, což potvrzuje její přínos ve strukturované intervenci u diabetu.Z pohledu klinické fenotypizace prof. Wei Qiang ukázal, že kombinace rutinních vstupních metrik s daty z CGM a AGP může pomoci identifikovat metabolické fenotypy a reakce na léčbu u hospitalizovaných
More news about: AGP & DTx Summit
Jun 05, 2026, 04:32 ET Summit AGP a DTx: digitálna terapia ukazuje zníženie HbA1c o 0,54 %, keďže starostlivosť o diabetikov prechádza od monitorovania k zmene
0,54 percentuálneho bodu, čo posilňuje jeho hodnotu v štruktúrovanej intervencii pri diabete.Z hľadiska klinického fenotypovania prof. Wei Qiang ukázal, že kombinácia bežných údajov pri hospitalizácii s údajmi z CGM a AGP môže pomôcť identifikovať metabolické fenotypy a reakcie na liečbu
More news about: AGP & DTx Summit
Jun 05, 2026, 04:23 ET Саммит AGP & DTx: цифровая терапия показывает снижение уровня HbA1c на 0,54% по мере того, как лечение диабета переходит от мониторинга к изменению
что подтверждает его ценность в структурированном вмешательстве при диабете.С точки зрения клинического фенотипирования, профессор Вэй Цян (Wei Qiang) показал, что сочетание показателей регулярной госпитализации с данными CGM и AGP может помочь идентифицировать метаболические фенотипы и
More news about: AGP & DTx Summit
Jun 04, 2026, 06:52 ET AGP & DTx Summit: Digital therapeutics show 0.54% HbA1c reduction as diabetes care moves from monitoring to change
reduction of 0.54 percentage points, reinforcing its value in structured diabetes intervention.From a clinical phenotyping perspective, Prof. Wei Qiang showed that combining routine admission metrics with CGM and AGP data may help identify metabolic phenotypes and treatment responses in hospitalized
More news about: AGP & DTx Summit
Jun 03, 2026, 10:16 ET Global Times: From aquaculture to green energy, Fangchenggang in S.China's Guangxi charts sustainable path toward the sea
trade) reached 170.55 billion yuan, up 10.3 percent year-on-year; the number of inbound and outbound vehicles reached 348,000, up 29.3 percent, Huang Wei, deputy director of the Dongxing Municipal Bureau of Commerce and Port Administration, told the Global Times.Meanwhile, cargo volume of imports
More news about: Global Times
Jun 03, 2026, 08:44 ET Orbit bringt Agent Builder auf den Markt, ein bedeutender Fortschritt für KI-gestützte Investmentforschung
warten zu müssen. Der Agent Builder von Orbit bietet ihnen genau das, da er direkt in die Plattform integriert ist, die sie bereits nutzen", sagt Da Wei, Gründer und CEO von Orbit.Wie es funktioniertJeder Orbit-Agent hat zwei Komponenten. Die erste wandelt die Anforderungen des
More news about: Orbit Financial Technology
Jun 03, 2026, 08:00 ET Orbit Launches Agent Builder, a Major Industry Leap Forward in AI Investment Research
research workflows without waiting on a vendor. Orbit's Agent Builder gives them exactly that, built natively into the platform they already use," said Da Wei, Founder & CEO of Orbit.How it worksEvery Orbit agent has two components. The first transforms the user's requirement into
More news about: Orbit Financial Technology
Jun 03, 2026, 08:00 ET Orbit Launches Agent Builder, a Major Industry Leap Forward in AI Investment Research
research workflows without waiting on a vendor. Orbit's Agent Builder gives them exactly that, built natively into the platform they already use," said Da Wei, Founder & CEO of Orbit.How it worksEvery Orbit agent has two components. The first transforms the user's requirement into
More news about: Orbit Financial Technology
Jun 03, 2026, 08:00 ET Orbit lanza Agent Builder, un importante avance en la investigación de inversiones con IA
de un proveedor. Agent Builder de Orbit les ofrece precisamente eso, estando integrado de forma nativa en la plataforma que ya utilizan», afirmó Da Wei, fundador y consejero delegado de Orbit.Cómo funcionaCada agente de Orbit cuenta con dos componentes. El primero transforma
More news about: Orbit Financial Technology
Jun 03, 2026, 08:00 ET Orbit lance Agent Builder, une avancée majeure dans le secteur de la recherche d'investissements optimisée par l'IA
fournisseur. C'est exactement ce que l'Agent Builder d'Orbit leur offre, intégré de manière native dans la plateforme qu'ils utilisent déjà », a déclaré Da Wei, fondateur et PDG d'Orbit.Comment cela fonctionne-t-il ?Chaque agent Orbit a deux composantes. La première transforme le besoin
More news about: Orbit Financial Technology
Jun 03, 2026, 02:01 ET ViewSonic Showcases AI-Enabled Learning and Integrated Visual Solutions Expansion
"Displays are evolving beyond traditional output devices into intelligent platforms that connect content, computing, and user experiences," said Eric Wei, Asia Pacific General Manager at ViewSonic. "As AI continues to reshape digital interaction across Asia, our focus is on making technology more intuitive,
More news about: ViewSonic Corp.